Table 5: Decision for a diagnostic clinical performance trial in the new region (specificity).

Δ

P new P

ρ

Decision New Region

Proportion of Subjects for bridging study

Sample size for bridging study

0.031

0.92

0.55

No Clinical Trial

.

.

0.032

0.91

0.54

No Clinical Trial

.

.

0.033

0.89

0.52

Bridging Study

0.073

122

0.034

0.88

0.51

Bridging Study

0.069

0.035

0.86

0.49

New Clinical Trial

.

.

0.036

0.84

0.48

New Clinical Trial

.

.